Management and Follow-up of Localized Wegener's Granulomatosis: A Review of Five Cases

References

• Nikolaou AC, Valchtsis KC, Daniilidis MA, Petridis DG, Daniilidis IC. Wegener's granulomatosis presenting with bilateral facial palsy. Eur Arch Otorhinolaryngol 2001; 258: 198–202.
   Google Scholar
• Takagi D, Nakamura Y, Maguchi S, Furuta Y, Fukuda S. Otologic manifestations of Wegener's granulomatosis. Laryngoscope 2002; 112: 1684–90.
   PubMedGoogle Scholar
• Fenton JE, O'Sullivan TJ. The otological manifestations of Wegener's granulomatosis. J Laryngol Otol 1994; 108: 144–6.
   PubMed Web of Science ®Google Scholar
• Moussa AEM, Abou-Elhmad KA. Wegener's granulo-matosis presenting as mastoiditis. Ann Otol Rhinol Laryngol 1998; 107: 560–3.
   PubMedGoogle Scholar
• Congdon D, Sherris DA, Specks U, McDonald T. Long-term follow-up of repair of external nasal deformities in patients with Wegener's granulomatosis. Laryngoscope 2002; 112: 731–7.
   PubMedGoogle Scholar
• Ahmad I, Lee WC, Nagendran V, Wilson F, Shortridge RTJ. Localized Wegener's granulomatosis in otolaryngology: a review of six cases. ORL J Otorhinolaryngol Relat Spec 2000; 62: 149–55.
   PubMedGoogle Scholar
• McDonald TJ, DeRemee RA. Head and neck involve-ment in Wegener's granulomatosis. In: Gross WL, ed. ANCA-associatedvasculitides;immuno-logical and clinical aspects. New York: Plenum Press; 1993. p. 309–13.
   Google Scholar
• Langford CA, Sneller MC. Update on the diagnosis and treatment of Wegener's granulomatosis. Adv Intern Med 2001; 46: 177–206.
   PubMedGoogle Scholar
• van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; i: 425–9.
   Google Scholar
• Variainen E, Nuutinen J. Head and neck manifestations of Wegener's granulomatosis. Ear Nose Throat J 1992; 71: 423–8.
   PubMedGoogle Scholar
• Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365–71.
   PubMed Web of Science ®Google Scholar
• Ohashi H, Itoh M, Ogawa N, Sudo Y, Endo S, Okugawa T, et al. Wegener's granulomatosis in a patient with rheumatoid arthritis. Intern Med 1992; 31: 1128–31.
   PubMedGoogle Scholar
• Chinoy H, McKenna F. Wegener's granulomatosis and rheumatoid arthritis overlap. Rheumatology 2002; 41: 588–9.
   PubMedGoogle Scholar
• Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–85.
   PubMed Web of Science ®Google Scholar
• Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology 2001; 40: 492–8.
   PubMed Web of Science ®Google Scholar
• Wegener F. Wegener's granulomatosis. Eur Arch Otor-hinolaryngol 1990; 247: 133–42.
   Google Scholar
• Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granuloma-tosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–94.
   PubMed Web of Science ®Google Scholar
• Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. Analysis of 42 Wegener's granulomatosis patients treated with methotrexate and prednisolone. Arthritis Rheum 1995; 38: 608–13.
   Google Scholar
• Langford CA, Talar-Williams C, Barron KS, Sneller MC. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorti-coids and daily cyclophosphamide switching to metho-trexate for remission maintenance. Arthritis Rheum 1999; 42: 2666–73.
   PubMed Web of Science ®Google Scholar
• Reinhold-Kellar E, Fink COE, Herlyn K, Gross WL, de Groot KD. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remis-sion with low-dose methotrexate. Arthritis Rheum 2002; 47: 326–32.
   Google Scholar
• Israel H. Sufamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med 1988; 148: 2293–5.
   PubMedGoogle Scholar
• Valeriano-Marcet J, Spiera H. Treatment of Wegener's granulomatosis with sufamethoxazole-trimethoprim. Arch Intern Med 1991; 151: 1649–52.
   Google Scholar
• Bullen CL, Liesgang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology 1983; 90: 279–90.
   PubMed Web of Science ®Google Scholar
• Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener's granulomatosis: an otorhi-nolaryngologist's perspective. Curr Opin Rheumatol 2001; 13: 3–11.
   PubMed Web of Science ®Google Scholar